Papua New Guinea vs Singapore: Treatment success rate for patients treated for MDR-TB
Papua New Guinea
33.0%
in 2022
Singapore
39.0%
in 2022
Papua New Guinea rank
151st
Singapore rank
150th
Treatment success rate for patients treated for MDR-TB over time
- Papua New Guinea
- Singapore
How they compare
Singapore currently reports 39.0% against 33.0% in Papua New Guinea, a difference of 6.0%.
That makes Singapore's figure about 1.2 times Papua New Guinea's.
The two have swapped places 2 times across 13 shared years of data; in 2006 it was Singapore ahead.
Papua New Guinea ranks 151st and Singapore ranks 150th of 163 countries.
Across the 3 decades both report, Papua New Guinea averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Papua New Guinea | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 67.0% | 57.0% | Singapore |
| 2010s | 56.3% | 55.8% | 0.6% | Papua New Guinea |
| 2020s | 52.7% | 36.7% | 16.0% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Papua New Guinea or Singapore?
- Singapore, at 39.0% against 33.0% in Papua New Guinea as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Papua New Guinea and Singapore?
- 6.0%, with Singapore ahead.
- How many years of comparable data are there for Papua New Guinea and Singapore?
- 13 years are reported by both, from 2006 to 2022.
- How do Papua New Guinea and Singapore rank globally for treatment success rate for patients treated for mdr-tb?
- Papua New Guinea ranks 151st and Singapore ranks 150th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.